after circulatory death; dP/dt max , maximum first derivative of left ventricular pressure; dP/dt min , minimum first derivative of left ventricular pressure; HY, hypoxia; IR, ischemia and reperfusion; KHB, Krebs-Henseleit bicarbonate buffer; LV, left ventricular; MH, mild hypothermia; MPC, mechanical postconditioning; mtDNA, mitochondrial DNA; mtDNA:nDNA, mitochondrial DNA-nuclear DNA ratio; mtPTP, mitochondrial permeability transition pore; nDNA, nuclear DNA; Nrf1, nuclear respiratory factor 1; Nrf2, nuclear respiratory factor 2; O 2 , oxygen; O 2 :T, oxygen consumption-triple product ratio; O 2 C, oxygen consumption; PCr, phosphocreatine; Pgc-1α, peroxisome proliferator-activated receptor-gamma coactivator 1α; Pgc-1β, peroxisome proliferator-activated receptor-gamma coactivator 1β; ROS, reactive oxygen species; SD, standard deviation; TBARS, thiobarbituric acid reactive substances; Tfam, transcription factor A, mitochondrial; TnT, troponin-T. Donation after circulatory death (DCD) holds great promise for improving cardiac graft availability; however, concerns persist regarding injury following warm ischemia, after donor circulatory arrest, and subsequent reperfusion. Application of preischemic treatments is limited for ethical reasons; thus, cardioprotective strategies applied at graft procurement (reperfusion) are of particular importance in optimizing graft quality. Given the key role of mitochondria in cardiac ischemia-reperfusion injury, we hypothesize that 3 reperfusion strategies-mild hypothermia, mechanical postconditioning, and hypoxia, when briefly applied at reperfusion onset-provoke mitochondrial changes that may underlie their cardioprotective effects. Using an isolated, working rat heart model of DCD, we demonstrate that all 3 strategies improve oxygen-consumption-cardiac-work coupling and increase tissue adenosine triphosphate content, in parallel with increased functional recovery. These reperfusion strategies, however, differentially affect mitochondria; mild hypothermia also increases phosphocreatine content, while mechanical postconditioning stimulates mitochondrial complex I activity and reduces cytochrome c release (marker of mitochondrial damage), whereas hypoxia upregulates the expression of peroxisome proliferator-activated receptor-gamma coactivator (regulator of mitochondrial biogenesis). Characterization of the role of mitochondria in cardioprotective reperfusion strategies should aid in the identification of new, mitochondrial-based therapeutic targets and the development of effective reperfusion strategies that could ultimately facilitate DCD heart transplantation. 
Donation after circulatory death (DCD) holds great promise for improving cardiac graft availability; however, concerns persist regarding injury following warm ischemia, after donor circulatory arrest, and subsequent reperfusion. Application of preischemic treatments is limited for ethical reasons; thus, cardioprotective strategies applied at graft procurement (reperfusion) are of particular importance in optimizing graft quality. Given the key role of mitochondria in cardiac ischemia-reperfusion injury, we hypothesize that 3 reperfusion strategies-mild hypothermia, mechanical postconditioning, and hypoxia, when briefly applied at reperfusion onset-provoke mitochondrial changes that may underlie their cardioprotective effects. Using an isolated, working rat heart model of DCD, we demonstrate that all 3 strategies improve oxygen-consumption-cardiac-work coupling and increase tissue adenosine triphosphate content, in parallel with increased functional recovery. These reperfusion strategies, however, differentially affect mitochondria; mild hypothermia also increases phosphocreatine content, while mechanical postconditioning stimulates mitochondrial complex I activity and reduces cytochrome c release (marker of mitochondrial damage), whereas hypoxia upregulates the expression of peroxisome proliferator-activated receptor-gamma coactivator (regulator of mitochondrial biogenesis). Characterization of the role of mitochondria in cardioprotective reperfusion strategies should aid in the identification of new, mitochondrial-based therapeutic targets and the development of effective reperfusion strategies that could ultimately facilitate DCD heart transplantation.
| INTRODUC TI ON
Heart transplantation is currently the best option to improve quality of life and life expectancy of patients with end-stage heart failure.
However, the number of donors is largely insufficient to cover the ever-increasing demand for hearts in both the European Union and the United States. 1, 2 One promising solution to this recurrent shortage is the use of grafts obtained from donors after circulatory death (DCD).
3
Despite groundbreaking demonstrations of clinical DCD heart transplantation in the last 4 years, [4] [5] [6] [7] concerns about graft quality persist. Indeed, DCD hearts are inevitably exposed to warm, global ischemia between circulatory arrest and procurement that can rapidly lead to tissue damage. Nonetheless, donor hearts can withstand a short period of warm ischemia; its duration has been limited to 30 minutes in recent DCD heart transplantations. 8 As interventions in DCD donors are limited for ethical reasons, cardioprotective therapies applied immediately following the period of warm ischemia hold great promise to increase graft tolerance to ischemia-reperfusion (IR)-induced injury. [9] [10] [11] [12] In current clinical practice, cardiac grafts are reperfused immediately following warm ischemia with either cold cardioplegia supplemented with erythropoietin and glyceryl nitrate with 4 or without 5 heparin (direct procurement protocol), or they are reperfused in situ, following heparinization, with donor blood (normothermic regional perfusion protocol). 6 Therefore, differing approaches are used for reperfusion following warm ischemia in the clinical setting, and it is likely that further development of alternative and/or complementary reperfusion strategies will contribute toward the optimization of graft quality. 8 Mitochondria play an important role in cardiac IR injury. During cardiac ischemia, reliance on glycolysis leads to intracellular acidosis and Ca 2+ overload, which contribute to the progressive deterioration of mitochondrial structure and function. 13 During reperfusion, recovery of mitochondrial oxidative phosphorylation for adenosine triphosphate (ATP) generation is a critical requirement for recovery of cardiac function. However, mitochondria themselves contribute to cellular damage at reperfusion, through the exacerbated production of reactive oxygen species (ROS). ROS damage cellular membranes and increase the sensitivity of mitochondrial permeability transition pore (mtPTP) to Ca
2+
. 13 With the normalization of intracellular pH at the onset of reperfusion, these processes lead to the opening of mtPTP, which can trigger mitochondrial destruction and cell death.
13
For these reasons, preservation of mitochondrial function and integrity during the first minutes of reperfusion is of central importance for optimizing recovery of hearts exposed to warm ischemia.
14,15
We have previously described 3 physical strategies as cardioprotective: mild hypothermia (MH), mechanical postconditioning (MPC), and hypoxia (HY), when applied during the first minutes of reperfusion following global, warm ischemia. 9 Interestingly, MH has been reported to prevent mtPTP opening when applied at reperfusion for 1 hour or 30 minutes in both in vivo or in vitro models of IR, respectively. 16, 17 In addition, MPC has been linked with better-preserved mitochondrial function, including limited ROS production and delayed mtPTP opening. 10, [18] [19] [20] [21] Furthermore, although HY would be expected to protect mitochondria by reducing or slowing the ROS burst at reperfusion, its antioxidative effect is still under debate. 22, 23 In summary, MH, MPC, and HY all demonstrate cardioprotective effects and although underlying mechanisms remain incompletely understood, evidence supports roles for cardiac mitochondria.
Therefore, we hypothesize that all 3 physical cardioprotective strategies (MH, MPC, and HY) provoke mitochondrial changes that may underlie their cardioprotection effects. In this study, we report our investigation into mitochondrial changes induced by the application of these strategies in an isolated rat heart model of DCD.
| MATERIAL S AND ME THODS

| Animals and ethical statement
Male Wistar rats obtained from Janvier Labs (Le Genest-Saint-Isle, France) were housed under standard conditions with unrestricted access to food and water. Animal handling was in compliance with the European legislation (86/609/EEC) and the Swiss Animal Protection Ordinance.
| Study design
An isolated, perfused heart was used as a model of DCD. Importantly, this model was used to simulate the period of warm, global ischemia to which DCD organs are exposed. In our experimental model, hearts were perfused ex situ prior to ischemia, and cardioprotective strategies were applied using a warm (30°C or 37°C), physiologic crystalloid buffer perfusate in order to precisely control the conditions to which the hearts were exposed and to limit potentially negative effects of donor blood or cold cardioplegia. Furthermore, directly after the application of cardioprotective strategies in an initial period of unloaded reperfusion, we proceeded with a loaded perfusion period to assess functional recovery in order to limit the effects of potentially confounding factors that may occur with additional cardioplegic/storage periods. Figure 1 ).
| Isolated, working heart preparation
Hearts were procured and initially perfused in Langendorff mode with modified Krebs-Henseleit bicarbonate buffer (KHB) within 2 minutes of diaphragm transection. 9 The left atrium was then cannulated, and the perfusion switched to loaded (working) mode. 24 
| Perfusion protocol
All hearts were initially submitted to 20 minutes of aerobic, working baseline perfusion (afterload 80 mm Hg) with modified KHB. 9 During this period, the perfusate was supplemented with 1.2 mmol/L palmitate and 3% bovine serum albumin to simulate high preischemic circulating fatty acid levels, as expected in clinical DCD. 25 Unless F I G U R E 1 Experimental design. Hearts were randomly allocated to 1 of 5 parallel-arm, experimental groups: (a) control group; hearts were subjected to warm, global ischemia and reperfusion with no cardioprotective strategy; (b-d) treated ischemic groups; immediately after warm, global ischemia, 1 controlled reperfusion strategy (MH, MPC, or HY) was applied; and (e) sham group (nonischemic control); hearts were perfused in aerobic conditions for the entire perfusion period. All hearts initially underwent a 20-min, aerobic baseline period, loaded mode (afterload pressure 80 mm Hg) with KHB (see composition in supplemental material) supplemented with 1.2 mmol/L palmitate and 3% albumin. Control, MH, MPC, and HY groups were then subjected to 27-min, normothermic global ischemia followed by 60-min reperfusion, while hearts in the sham group were maintained in baseline perfusion conditions for the equivalent time (27 min) to generate nonischemic control hearts. In all groups, hearts were reperfused for 60 min using KHB without palmitate and albumin supplementation. Reperfusion was initiated in unloaded mode for the first 10 min and then switched to loaded mode for the remaining 50 min (afterload 60 mm Hg Table S3 .
| RE SULTS
| Baseline characteristics
Absolute values for perfusion parameters measured at 20 minutes of baseline, as well as rat body and heart weights, are Table S1 . A total of 39 rats were included: sham (n = 8); control (n = 8); MH (n = 8); MPC (n = 8); and HY (n = 7). All parameters were similar between the ischemic, nontreated (control) group and reperfusion-strategy groups, except for a higher body weight in the HY group (P < .05 vs control). Baseline values measured for the sham group, however, tended to differ from other groups and some, essentially cardiac output (CO), reached statistical significance.
| Postischemic recovery
Cardiac recovery is presented as percentage (60 minutes Table S2 .
| Oxygen metabolism
Oxygen consumption (O 2 C) was significantly decreased at 20, 40, and 60 minutes reperfusion in control vs sham hearts (P < .05 for all), and significantly increased with MPC compared to controls at 40 and 60 minutes reperfusion (P < .05 at 40 minutes; P < .01 at 60 minutes; Figure 3A ). Oxygen consumption-triple product ratio Absolute values for these parameters at 60 minutes reperfusion are shown in Table S2 .
| Release of markers of cellular death and mitochondrial damage during reperfusion
Release of troponin-T (TnT) and cytochrome c (cyt c) as well as lactate accumulation, were significantly increased in control vs sham hearts at all time points (P < .05 for all; Figure 4A ,C,D). Lactate dehydrogenase was not detectable in sham hearts ( Figure 4B ). MPC was the only strategy to significantly modify these markers compared to control hearts; specifically, MPC increased TnT release at 10 minutes reperfusion (P < .05, Figure 4A ) and decreased the release of cyt c at 40 minutes reperfusion (P < .05, Figure 4C ).
| Myocardial energy status
ATP content measured at 60 minutes reperfusion was reduced by 62% in the control compared to the sham group (P < .001; Figure 5A ). Interestingly, all reperfusion strategies partially restored ATP levels (P < .05 MPC and HY vs control; P < .001 MH vs control). Phosphocreatine (PCr) content was also reduced in the control compared to sham group (P < .05), but to a lesser extent than ATP (25% reduction; Figure 5B ), and MH restored PCr content (P < .05 MH vs control) to values comparable to those in sham hearts. In parallel with ATP, adenosine diphosphate (ADP) content was reduced by 44% in the control compared to the sham group (P < .01; Figure 5C ). ADP content was also reduced in all reperfusion strategy groups vs sham (P < .01 for all), and appeared to be slightly lower than that in the control group, although not statistically different. Consequently, the ATP-ADP ratio (ATP:ADP) was almost identical in ischemic, nontreated (control) and sham hearts, and it tended to be slightly increased,
although not statistically significant, in all reperfusion strategy groups ( Figure 5D ). 
| Mitochondrial content
No significant difference was observed between control and sham groups for citrate synthase (CS) activity ( Figure 7A ), nor for cytochrome c oxidase (COX) activity ( Figure 7B ). In contrast, the mitochondrial DNA-nuclear DNA ratio (mtDNA:nDNA) was significantly increased in control compared to sham hearts (P < .001; Figure 7C ).
Reperfusion strategies did not modify any of these parameters compared to control values.
| mRNA expression of genes involved in mitochondrial biogenesis
Twenty seven minutes of ischemia followed by 60 minutes of reperfusion did not significantly modify the mRNA expression of genes involved in the mitochondrial biogenesis pathway ( Figure 8A-E) .
HY was the sole strategy to significantly elevate the expression of PGC-1α, a master regulator of mitochondrial biogenesis, compared to the control group (P < .05; Figure 8D ).
| Markers of oxidative stress
Cardiac thiobarbituric acid reactive substances (TBARS) content was similar among experimental groups ( Figure 9A ), while protein carbonylation was significantly increased in control vs sham hearts (P < .01; Figure 9B ). Reperfusion strategies did not modify either of these parameters compared to control values.
| Correlations between mitochondrial, metabolic, and contractile parameters
Correlation analyses were performed to investigate relationships between cardiac recovery at 60 minutes reperfusion and either 
| D ISCUSS I ON
Using our isolated, working rat heart model of DCD, we report that 3, briefly applied reperfusion strategies (MH, MPC, and HY) improve postischemic cardiac functional recovery in association with modification of mitochondrial-related parameters. Although these strategies induced differing effects on mitochondria, all provoked a greater recovery of ATP stores and quicker normalization of oxygen consumption-cardiac work coupling compared to untreated controls.
To our knowledge, this is the first demonstration that a reduction in temperature of a few degrees, applied as a cardioprotective strategy In preclinical models of DCD, cardioprotective effects of MH have been previously reported when applied for longer periods during reperfusion (1-3 hours), 27, 28 16 or reduce cellular oxidative stress, 27 our results reveal that only a very short application of MH (10 minutes) at the beginning of reperfusion is required to induce a significant improvement in repletion of high-energy metabolites over the first hour of reperfusion.
We also report that MPC preserves postischemic cardiac function, in association with increased ATP levels and mitochondrial CI activity. MPC is a reperfusion strategy that has been widely studied, 10, [18] [19] [20] [21] [30] [31] [32] although its precise mechanism of action remains to be elucidated. Our observation of MPC-induced increases in cardiac ATP content agrees with previous studies, 19, 20, 30 and it is tempting to speculate that increased mitochondrial CI activity contributes to these higher ATP levels. However, previous studies have demonstrated varying effects of MPC on mitochondrial CI activity. 10, 18, 31 It should be noted that mitochondrial CI is of particular importance in IR injury as it is the main cellular producer of ROS. 33 As such, our finding of higher mitochondrial CI activity could be associated with higher ATP synthesis, but also it could lead to excessive ROS production. Importantly, in MPC hearts compared to controls, cyt c release, a recognized indicator of mitochondrial damage, 34 was significantly reduced at 40 minutes reperfusion and oxidative stress at 60 minutes reperfusion was not increased (although we cannot exclude the possibility that greater oxidative stress was induced by MPC at earlier reperfusion time points). Thus, our findings support the concept that MPC induced mitochondrial CI activation and preserved mitochondrial integrity, which may contribute to greater ATP content and contractile recovery.
To our knowledge, we are the first to reveal that short hypoxic conditions at reperfusion onset (HY) promote postischemic recovery of cardiac contractile function in parallel with higher ATP content.
HY was aimed to reduce the burst of mitochondrial ROS production that accompanies oxygen reintroduction at reperfusion. However, others have reported that similar strategies provoke either cardioprotection and antioxidant effects, 22, 35 or a lack of protection in combination with heightened oxidative stress. 23 We did not observe HY-induced reductions in overall (net) oxidative stress; however, our investigations do not provide insight as to whether ROS production and/or antioxidant capacity in these hearts was altered by HY.
Further investigation is required to answer these specific questions.
Strikingly, we demonstrate for the first time that HY increases CK activity compared to most other experimental conditions. This is of particular interest in light of recent reports that in vitro 36 or ex vivo 37 overexpression of specific CK isoforms is cardioprotective. Thus, our novel demonstration of HY-induced CK activation merits further investigation to determine its importance in cardioprotection, as well as the underlying mechanisms.
The application of reperfusion strategies stimulated ATP repletion during reperfusion. We report a substantial decrease in tissue ATP content after 27 minutes of warm, global ischemia and 60 minutes of reperfusion: a 62% reduction vs nonischemic values. This marked decrease contrasts with studies using unloaded (Langendorff) heart perfusions. 19, 20, 27, 30 In our study, the maximum reperfusion-strategy-induced repletion reached ≈50% nonischemic values, whereas in "unloaded" models, similar strategies fully restored the ATP content. 19, 20, 27, 30 It is unclear why we observe lower postischemic ATP levels, but it may be due to greater ATP demand as a consequence of our experimental conditions: tight ischemic temperature control (36.5°C-37.2°C) and a loaded heart preparation. 38 We also report a drop in tissue ADP content after IR, similar to other animal models. 39, 40 However, reperfusion strategies tended to further decrease ADP levels, leading to a trend toward higher ATP:ADP in reperfusion strategy, compared to control groups, although these changes did not reach statistical significance. Interestingly, it has been suggested that during reperfusion, cardiac ATP is partially restored at the expense of ADP and adenosine monophosphate, 39, 40 which is consistent with the tendency that we observe, for an increased ATP:ADP following application of reperfusion strategies. Nonetheless, there appears to be considerable room for improvement in efficacy of the strategies with respect to ATP repletion. Possible approaches could include perfusate supplementation with stimulators of ATP synthesis, such as adenosine, 41 trimetazidine, 42 or bendavia.
43,44
We did not observe IR-induced changes in the activities of CII, AK, and CK. These findings are comparable to previous reports in heart homogenates 45 or isolated mitochondria. 46 Interestingly, activities of all complexes (I-IV) were reduced after ischemia, activities of complexes II and IV returned to preischemic levels after 1 hour reperfusion. 46 Thus, it could be that at the time of our analysis, after 1 hour reperfusion, ischemia-induced alterations in mitochondrial-related enzymes had already been normalized.
Studies aimed to unravel the mechanisms of action at early reperfusion are therefore envisaged.
We monitored 3 different indicators of mitochondrial mass.
While the postischemic activities of CS and COX were unchanged between sham and control groups, the mtDNA:nDNA was substantially elevated in control compared to sham hearts. Unchanged mitochondrial enzyme activities are comparable to previous reports. 45, 46 However, varying effects of cardiac IR on mtDNA have been reported. IR has been associated with mtDNA damage at early reperfusion 47 and upregulation of genes involved in mtDNA replication. 45 The IR-induced increase in mtDNA:nDNA that we observe should be interpreted with caution due to the short timeframe of our study
(1-hour reperfusion). Unlike the study of Marín-García, 45 we did not observe modifications in the activation of the mtDNA transcription.
However, the higher release in cyt c that we report after IR does suggest greater mitochondrial damage. Therefore, the increased mtDNA:nDNA in control vs sham hearts might be a consequence of accumulated mitochondrial damage within the cell, due to inefficient mitophagy. Indeed, lack of mitophagy has previously been associated with exacerbated IR injury. 48, 49 Interestingly, in our study, HY significantly increased mRNA levels of Pgc-1α, the master regulator of mitochondrial biogenesis. HY-induced Pgc-1α expression, which has been described in cardiomyocytes after 24 hours exposure to hypoxia, 50 is intriguing as a potential contributor to cardioprotection, and may thus prompt further studies.
TBARS and protein carbonylation were investigated as markers of oxidative stress. No difference among experimental groups was observed for TBARS. Indeed, it has been shown that TBARS may provide a better marker of oxidative stress at early reperfusion. 51 However, protein carbonylation was significantly increased in control vs sham hearts, and reperfusion strategies did not limit this increase. Contrary to previous reports, 17 We would like to highlight several limitations that apply to our work. First, in order to limit variability and to precisely control our experimental conditions, we used an isolated heart model that is not fully representative of conditions to which human cardiac grafts are exposed in clinical DCD. Indeed, hearts in our model are not subjected to the catecholamine surge and pulmonary vasoconstriction, previously described in larger animal models of DCD after withdrawal of life-sustaining therapy, 54, 55 that are particularly damaging for the right ventricle. Furthermore, we must also point out that our postischemic findings can be considered only as short-term recovery, as we monitored heart function for a total of 1 hour after reperfusion onset. This is of particular clinical relevance as graft dysfunction may not develop until several hours posttransplant. In addition, we have included only males in our study in order to avoid sex-related variability in the response to IR injury due to hormonal differences. 56 Nonetheless, sex differences are potentially of great relevance in cardioprotection and merit further F I G U R E 11 Correlation analysis of mitochondrial, metabolic, and cell death measures at 10-min reperfusion with recovery parameters measured at 60-min reperfusion. Spearman correlations were performed for (A) pooled control and mild hypothermia groups, (B) pooled control and mechanical postconditioning groups, and (C) pooled control and hypoxia groups. Rho values are indicated by the color scale. *P < .05, **P < .01, £ P < .001. 
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